Theraclion SA
PAR:ALTHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Theraclion SA
Cash from Investing Activities
Theraclion SA
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Theraclion SA
PAR:ALTHE
|
Cash from Investing Activities
-€295.6k
|
CAGR 3-Years
26%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Cash from Investing Activities
-€5.7m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-25%
|
|
|
Biomerieux SA
PAR:BIM
|
Cash from Investing Activities
-€461.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Cash from Investing Activities
-€2.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Cash from Investing Activities
-€1.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Cash from Investing Activities
-€14.8m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Theraclion SA
Glance View
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
See Also
What is Theraclion SA's Cash from Investing Activities?
Cash from Investing Activities
-295.6k
EUR
Based on the financial report for Dec 31, 2025, Theraclion SA's Cash from Investing Activities amounts to -295.6k EUR.
What is Theraclion SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-9%
Over the last year, the Cash from Investing Activities growth was -57%. The average annual Cash from Investing Activities growth rates for Theraclion SA have been 26% over the past three years , -9% over the past five years .
